Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1989 2
1990 1
1991 1
1992 3
1993 3
1994 1
1995 3
1997 3
1998 3
1999 3
2000 1
2001 5
2002 4
2003 6
2004 5
2005 6
2006 5
2007 14
2008 11
2009 13
2010 6
2011 14
2012 14
2013 22
2014 17
2015 15
2016 9
2017 12
2018 17
2019 14
2020 15
2021 20
2022 15
2023 17
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

268 results

Results by year

Filters applied: . Clear all
Proximity search should include two or more words. Proximity operator ignored :~0
Page 1
AGA Clinical Practice Update on the Personalized Approach to the Evaluation and Management of GERD: Expert Review.
Yadlapati R, Gyawali CP, Pandolfino JE; CGIT GERD Consensus Conference Participants. Yadlapati R, et al. Clin Gastroenterol Hepatol. 2022 May;20(5):984-994.e1. doi: 10.1016/j.cgh.2022.01.025. Epub 2022 Feb 2. Clin Gastroenterol Hepatol. 2022. PMID: 35123084 Free PMC article. Review.
When there is adequate response, PPI should be tapered to the lowest effective dose. BEST PRACTICE ADVICE 5: If PPI therapy is continued in a patient with unproven GERD, clinicians should evaluate the appropriateness and dosing within 12 months after initiation, and offer …
When there is adequate response, PPI should be tapered to the lowest effective dose. BEST PRACTICE ADVICE 5: If PPI therapy is contin …
ACG Clinical Guideline: Gastroparesis.
Camilleri M, Kuo B, Nguyen L, Vaughn VM, Petrey J, Greer K, Yadlapati R, Abell TL. Camilleri M, et al. Am J Gastroenterol. 2022 Aug 1;117(8):1197-1220. doi: 10.14309/ajg.0000000000001874. Epub 2022 Jun 3. Am J Gastroenterol. 2022. PMID: 35926490 Free PMC article.
Gastroparesis is characterized by symptoms suggesting retention of food in the stomach with objective evidence of delayed gastric emptying in the absence of mechanical obstruction in the gastric outflow. ...These guidelines summarize perspectives on the risk factors, diagn …
Gastroparesis is characterized by symptoms suggesting retention of food in the stomach with objective evidence of delayed gastric emp …
Chronic nausea and vomiting: evaluation and treatment.
Lacy BE, Parkman HP, Camilleri M. Lacy BE, et al. Am J Gastroenterol. 2018 May;113(5):647-659. doi: 10.1038/s41395-018-0039-2. Epub 2018 Mar 15. Am J Gastroenterol. 2018. PMID: 29545633 Review.
The prevalence of chronic nausea and vomiting is unclear, although the epidemiology of specific conditions, such as gastroparesis and cyclic vomiting syndrome, is better understood. The economic impact of chronic nausea and vomiting and effects on quality of life are subst …
The prevalence of chronic nausea and vomiting is unclear, although the epidemiology of specific conditions, such as gastroparesis and …
Clinical guideline: management of gastroparesis.
Camilleri M, Parkman HP, Shafi MA, Abell TL, Gerson L; American College of Gastroenterology. Camilleri M, et al. Am J Gastroenterol. 2013 Jan;108(1):18-37; quiz 38. doi: 10.1038/ajg.2012.373. Epub 2012 Nov 13. Am J Gastroenterol. 2013. PMID: 23147521 Free PMC article.
This guideline presents recommendations for the evaluation and management of patients with gastroparesis. Gastroparesis is identified in clinical practice through the recognition of the clinical symptoms and documentation of delayed gastric emptying. ...Attention sh …
This guideline presents recommendations for the evaluation and management of patients with gastroparesis. Gastroparesis is ide …
Gastroparesis: a turning point in understanding and treatment.
Grover M, Farrugia G, Stanghellini V. Grover M, et al. Gut. 2019 Dec;68(12):2238-2250. doi: 10.1136/gutjnl-2019-318712. Epub 2019 Sep 28. Gut. 2019. PMID: 31563877 Free PMC article. Review.
The stagnant gastroparesis therapeutic landscape is likely to soon see significant changes. ...This review highlights the clinical presentation, diagnosis, mechanisms and treatment advancements for gastroparesis....
The stagnant gastroparesis therapeutic landscape is likely to soon see significant changes. ...This review highlights the clin …
Azithromycin for the treatment of gastroparesis.
Potter TG, Snider KR. Potter TG, et al. Ann Pharmacother. 2013 Mar;47(3):411-5. doi: 10.1345/aph.1R541. Epub 2013 Feb 27. Ann Pharmacother. 2013. PMID: 23447477 Review.
OBJECTIVE: To evaluate the use of azithromycin for the treatment of gastroparesis. DATA SOURCES: Literature was accessed through PubMed/MEDLINE and Web of Science (both 1966-October 2012) using the terms gastroparesis, diabetic gastroparesis, and azithromycin …
OBJECTIVE: To evaluate the use of azithromycin for the treatment of gastroparesis. DATA SOURCES: Literature was accessed through PubM …
AGA Clinical Practice Update on Management of Medically Refractory Gastroparesis: Expert Review.
Lacy BE, Tack J, Gyawali CP. Lacy BE, et al. Clin Gastroenterol Hepatol. 2022 Mar;20(3):491-500. doi: 10.1016/j.cgh.2021.10.038. Epub 2021 Oct 29. Clin Gastroenterol Hepatol. 2022. PMID: 34757197 Review.
DESCRIPTION: Delayed gastric emptying on objective testing defines gastroparesis, but symptoms overlap with functional dyspepsia and do not correlate well with gastric emptying delay. This review outlines a strategy for defining, diagnosing, and managing refractory gast …
DESCRIPTION: Delayed gastric emptying on objective testing defines gastroparesis, but symptoms overlap with functional dyspepsia and …
Treatment of autonomic dysfunction in Parkinson disease and other synucleinopathies.
Palma JA, Kaufmann H. Palma JA, et al. Mov Disord. 2018 Mar;33(3):372-390. doi: 10.1002/mds.27344. Mov Disord. 2018. PMID: 29508455 Free PMC article. Review.
Here, we review the treatment of autonomic dysfunction in patients with Parkinson disease and other synucleinopathies, summarize the nonpharmacological and current pharmacological therapeutic strategies including recently approved drugs, and provide practical advice and ma …
Here, we review the treatment of autonomic dysfunction in patients with Parkinson disease and other synucleinopathies, summarize the nonphar …
2023 update on the clinical management of gastroparesis.
El Halabi M, Parkman HP. El Halabi M, et al. Expert Rev Gastroenterol Hepatol. 2023 May;17(5):431-441. doi: 10.1080/17474124.2023.2196404. Epub 2023 Mar 29. Expert Rev Gastroenterol Hepatol. 2023. PMID: 36970885 Review.
Nausea, vomiting, early satiety, and postprandial fullness are the classic symptoms of gastroparesis. Gastroparesis is increasingly encountered by physicians. ...In this manuscript, we detail treatments evolving for gastroparesis, including nutritional, pharm …
Nausea, vomiting, early satiety, and postprandial fullness are the classic symptoms of gastroparesis. Gastroparesis is increas …
Systemic sclerosis gastrointestinal dysmotility: risk factors, pathophysiology, diagnosis and management.
McMahan ZH, Kulkarni S, Chen J, Chen JZ, Xavier RJ, Pasricha PJ, Khanna D. McMahan ZH, et al. Nat Rev Rheumatol. 2023 Mar;19(3):166-181. doi: 10.1038/s41584-022-00900-6. Epub 2023 Feb 6. Nat Rev Rheumatol. 2023. PMID: 36747090 Review.
The clinical complications of this dysfunction are heterogeneous and include gastro-oesophageal reflux disease, gastroparesis, small intestinal bacterial overgrowth, intestinal pseudo-obstruction, malabsorption and the requirement for total parenteral nutrition. ...Here, w …
The clinical complications of this dysfunction are heterogeneous and include gastro-oesophageal reflux disease, gastroparesis, small …
268 results